Graft function of encapsulated islets is restricted in spite of the fact that inflammatory responses against capsules are limited to a portion less than 10%. It has been shown that dysfunction is accompanied by a gradual decrease in the glucose-induced insulin response (GIIR), a hyperproliferation of islet cells, and gradual necrosis. Also, limited survival is associated with the presence of macrophages in the overgrowth. In the present study, we investigate whether macrophages are the inducers of dysfunction of encapsulated grafts. Four weeks after successful transplantation of microencapsulated rat allografts we determined the GIIR, the rate of islet cell replication, and islet cell death. Also, we quantified the number of macrophages on the overgrown capsules. This assessment was applied to set up an in vitro coculture system of macrophages and encapsulated islets. We retrieved 93 ± 6.2% of the capsules of which 9.2 ± 0.3% was overgrown. The GIIR of the retrieved nonovergrown islets was reduced when compared with freshly encapsulated islets. The replication rate of the retrieved islet cells was eightfold higher than in the normal pancreas. Apoptosis was rarely observed but 37 ± 4% of the total islet surface was composed of necrosis. We found a mean of 1542 ± 217 macrophages per capsule. Coculture of 1500 NR8383 macrophages per encapsulated islets induced a substantial reduction in GIIR but a decrease instead of increase in replication. Necrosis was restricted to 13 ± 1.3% of the islet cells and was not increased by the presence of macrophages. Our observations indicate that we should focus on reduction of macrophage activation and on improving the nutrition of encapsulated islets to prevent islet cell death.
INTRODUCTION
than fibrotic overgrowth with subsequent necrosis of the islets contribute to failure of the encapsulated islet grafts. These are islet-related factors such as limited life span Encapsulation in alginate-poly-L-lysine (PLL)-based microcapsules (22) is a commonly applied procedure for of islets (1, 15) but also indirect effects of the tissue response against the encapsulated islets, as will be dis-immunoprotection of pancreatic islets. During recent years, important advances have been made with this cussed in the next sections. The cellular overgrowth on the small portion of 2-technology. The introduction of pure and new types of alginates (7, 18, 28) and methods for testing the integrity 10% of the capsules is mainly composed of ED-1 and ED-2 macrophages (8). In a previous study we sug-of the capsules has been associated with a substantial reduction of fibrotic overgrowth from all capsules to a gested that these macrophages contribute to cessation of the graft not only by overgrowth and subsequent necro-portion of 2-10% of the capsules (7,13). This improvement of biocompatibility is beneficial for functional sis of the islets but also by secretion of cytokines with potential deleterious effects on the islets in 90-98% of graft survival, because normoglycemia was observed during 2 to 6 months in streptozotocin diabetic recipients nonovergrown encapsulated islets. The present study was undertaken to study the mech-of microencapsulated islet allo-and isografts (7, 23, 27) .
Although this illustrated the principle applicability of anism and quantify the effect of macrophages in the 2-10% overgrowth on the nonovergrown encapsulated the alginate encapsulation technique, a fundamental barrier needed to be overcome because graft survival varied islets. To this end, we studied transplanted microencapsulated islets at 4 weeks after implantation. At the time considerably in our studies from 2 to 6 months and was never permanent (5,7,11). Obviously, processes other of peritoneal lavage, encapsulated islets were tested for 516 DE VOS ET AL.
their ex vivo insulin response to glucose, the rate of islet Animals and Induction of Diabetes cell proliferation, and the percentage of nonviable tissue Male inbred Albino Oxford (AO/G) and Lewis rats in the islets because we have observed disturbed patterns were obtained from Harlan (Harlan CPB, Zeist, The for these parameters in previous studies (13). To investi-Netherlands) or the Central Animal Laboratory of Grongate whether these assessments are correlated with the ingen. NHI guidelines for the care and use of laboratory presence of macrophages in the immediate vicinity of animals were observed. encapsulated islets, we applied a coculture system of en-Male inbred Lewis rats weighing 300-350 g served capsulated islets with macrophages to mimic the in vivo as donors. Male inbred AO/G rats weighing 290-320 g situation.
were used as recipients of encapsulated islet grafts. Diabetes was induced by injection of 75-90 mg/kg of streptozotocin (Zanosar, Upjohn Co., Kalamazoo, MI) via the MATERIALS AND METHODS tail vein. Glucose concentration in blood was deter-Design of the Study mined with glucose test tapes (Reflolux, Boehringer Alginate-PLL microcapsules were implanted in the Mannheim, FRG). Only animals with severe weight peritoneal cavity (i.e., the usual transplantation site for loss, polyuria, polydipsia, and blood glucose levels exan encapsulated islet graft) of AO rats. Only highly puriceeding 20 mmol/L over a period of at least 4 weeks fied alginates were applied to exclude that contaminatwere used as recipients. To exclude β-cell regeneration, ing components were the cause of an inflammatory rewe always took a biopsy from the pancreas at the time sponse. The capsules were inspected before and after of peritoneal lavage. implantation to confirm that the majority of the capsules Islet Isolation were intact. The capsules were retrieved at 4 weeks postimplant by peritoneal lavage.
Islets were isolated as previously described (32). Briefly, under ether anesthesia, the abdomen was opened At the time of peritoneal lavage the encapsulated islets were divided in two portions. The first portion was and the common bile duct was cannulated under nonsterile conditions. The donor pancreas was distended applied to determine the ex vivo insulin response to glucose, the rate of islet cell proliferation, and the percent-with 10 ml sterile Krebs-Ringer-HEPES (KRH) supplemented with 25 mmol/L HEPES buffer and containing age of nonviable tissue in the islets. The second portion was used for determination of the percentage of over-10% bovine serum albumin (BSA). Subsequently, the pancreas was excised and brought into a laminar flow growth of the encapsulated graft and for quantification of the number of macrophages in the capsular overgrowth.
cabinet. All further procedures were performed under sterile conditions. The total volume of the graft recovered by peritoneal lavage was related to the initial volume of the transplant.
The pancreas was chopped, digested using a twostage incubation of 20 min at 37°C with successively The number of recovered capsules with cellular overgrowth was assessed by microscopy of histological sec-1.0 and 0.7 mg/ml collagenase (Sigma type XI, Sigma, St. Louis, MO). Islets were separated from exocrine tis-tions. This fraction was expressed as the percentage of the total number of recovered capsules.
sue by centrifugation over a discontinuous dextran gradient (31) and further purified by handpicking. The number of ED-1 and ED-2 positive macrophages in the overgrown capsules was quantified by microscopy The total islet volume was determined by measuring the diameters (30) of islets in a 4% aliquot of the islet of histological sections of the graft. The counted number of macrophages was related to the percentage of over-suspension. The diameters were measured with a dissection microscope with a fluorescent illuminator (Bausch grown capsules in the graft. The number of macrophages was expressed as the quantity of macrophages per cap-and Lomb BVB-125, and 31-33-66) equipped with an ocular micrometer with an accuracy of 25 µm. The total sule. These assessments were applied to culture rat macrophages (NR8383) with 100 encapsulated Lewis rat volume was calculated, assuming the islets to be perfect spheres. In each experiment we used four to five donors islets. After 48 h of coculture with macrophages, encapsulated islets were harvested and tested for their ability from which we isolated a total of 3500-4200 islets, which corresponds to 10-15 µl of islet tissue. to respond to a glucose load with an insulin response and processed for histological determination of the num-Islets were cultured before encapsulation to reduce contamination of the grafts with exocrine tissue, ducts, ber of replicating islet cells, and the percentage of nonviable tissue. Cocultures of LPS-activated rat macro-or damaged cells. They were cultured in nontreated petri dishes (Greiner, Alphen a/d Rijn, The Netherlands) in phages with encapsulated islets were applied to assess the protective effect of capsules for macrophage-derived portions of 100 islets per 25 cm 2 for 19-44 h in RPMI-1640 [containing 10% fetal calf serum (FCS, Gibco, cytokines. Cultures of encapsulated Lewis rat islets served as control.
Breda, The Netherlands), 8.3 mmol/L glucose, 10 mmol/ L HEPES, and 1% penicillin/streptomycin] at 37°C in sules were immediately fixed after lavage to avoid inappropriate activation of the adherent cells (vide infra). humidified air containing 5% CO 2 . After this culture period the total islet volume was assessed again. Graft From this tube, the microcapsules were brought into a measure cylinder to assess the retrieved volumes with endocrine volume was at least 10 µl, which is approximately equal to the endocrine volume of the normal rat an accuracy of 0.05 ml as described above. Also, we confirmed that the diameter of the capsules had not pancreas (31).
changed during implantation and subsequent fixation be-Microencapsulation cause a change in diameter of the capsules could interfere with adequate measurement of the retrieved graft After culture, islets were washed three to five times with RPMI containing 10% FCS and were subsequently volume (13). Subsequently, the microcapsules adhering to the surface of abdominal organs were excised and suspended in sterile filtered (0.2 µm filtration) 3-3.3% purified alginate solution. The alginate solution was processed for histology. converted into droplets using an air-driven droplet gen-Cell Cultures and Co-incubation erator as previously described (6,33). PLL-alginate encapsulation was performed as described elsewhere (17) .
Before starting the in vitro experiments we selected an appropriate macrophage source for mimicking the in Briefly, the alginate droplets were transformed to alginate beads by gelling in a 100 mM CaCl 2 (10 mM vivo situation. To this end, we first tested the feasibility of using residential macrophages either from overgrown HEPES, 2 mM KCl) solution for at least 5 min. Subsequently, the Ca-alginate beads were suspended for 1 capsules, from peripheral blood, or (proteose-peptoneelicited) peritoneal macrophages (2) . This was done by min in KRH containing 2.5 mmol/L CaCl 2 . A PLL membrane was formed by suspending the alginate beads in comparing the number of iNOS-positive macrophages obtained from the in vitro system with those collected 0.1% PLL solution for 10 min (PLL-HCl, MW 22,000, Sigma). Nonbound PLL was removed by three succes-in vivo on capsules directly fixed after being flushed from the peritoneal cavity. Unfortunately, none of the sive washings during 3 min with Ca 2+ -free KRH containing 135 mM NaCl. The outer alginate layer was subse-sources were adequate for application in the in vitro system because isolation and processing of the macro-quently applied by 5-min incubation in 10 times diluted alginate solution. The capsules had a diameter of 600-phages for in vitro application were associated with strong and inappropriate activation of the cells as evi-700 µm as measured with a dissection microscope (Bausch and Lomb BVB125) equipped with an ocular denced by iNOS expression in 80-95% of the macrophages, while it was always less than 50% of the macro-micrometer with an accuracy of 10 µm. The total graft volume was determined in a measure cylinder, with an phages directly fixed after flushing from the peritoneal cavity. Another reason prohibiting the use of the above-accuracy of 0.05 ml.
mentioned macrophages as a cell source was that it was Transplantation and Retrieval not applicable for long-term cultures because a substanof Microencapsulated Islets tial number of the macrophages died within hours after starting the incubations at 37°C. Therefore, in our subse-Under halothane anesthesia, the microencapsulated islets were injected into the peritoneal cavity with a 16-quent approach we concentrated on finding an appropriate macrophage cell line instead of resident macro-gauge cannula via a small incision (3 mm) in the linea alba. The abdomen was closed with a two-layer suture.
phages. In total we have tested the adequacy of eight different The implanted volumes varied between 2.0 and 2.5 ml. Blood glucose was determined at regular time intervals cell lines. In these tests we not only studied and compared iNOS expression but also the ability of the cell in blood sampled from the tail vein. The glucose concentration was determined with glucose test tapes (Re-line to secrete IL-1β and TNF-α in a dose-dependent fashion upon activation with lipopolysaccharide (LPS, flolux). Recipients with a blood glucose level less than 8.4 mmol/L were considered normoglycemic.
E. coli, Sigma). Only the Sprague-Dawley macrophage cell line NR8383 (ATCC, Manassas, VA) (19) proved Microcapsules were retrieved at 4 weeks after transplantation. Microcapsules were mostly freely floating to be adequate for application in our test system because processing for culture was not associated with increased and nonadherent, but occasionally we found some capsules adhering to the surface of intra-abdominal organs.
expression of iNOS and it was one of the few cell lines that was found to secrete IL-1β and TNF-α in a dose-First, nonadherent microcapsules were retrieved by peritoneal lavage, performed by infusing 20 ml KRH dependent fashion upon activation with LPS. Before application in the experiments, the NR8383 through a 3-cm midline incision into the peritoneal cavity and subsequent flushing with additional KRH for two macrophage cell line was cultured in 60-ml culture flasks containing RPMI-1640 with 10% fetal calf serum, or three times above a 50-ml centrifuge tube. The cap-8.3 mmol/L glucose, 10 mmol/L HEPES, and 1% peni-of samples of 25 islets each. Consequently, the insulin secretory responses of islets from in vitro culture experi-cillin/streptomycin. The cultures were kept at 37°C in humidified air containing 5% CO 2 .
ments were expressed as nanogram of insulin ml −1 10 islets −1 45 min −1 . In the co-incubation experiment four separate samples of 100 encapsulated islets were incubated with an Histology and Assessment of Capsular Overgrowth appropriate quantity of macrophages (see Results section) in 12-well plates and subsequently cultured for 48 Nonadherent capsules recovered by peritoneal lavage were always divided in three portions. One portion was h in RPMI-1640 with 10% fetal calf serum, 8.3 mmol/ L glucose, 10 mmol/L HEPES, and 1% penicillin/strep-fixed in precooled 2% paraformaldehyde, buffered with 0.05 M phosphate, and processed for GMA embedding tomycin at 37°C in humidified air containing 5% CO 2 . As a negative control on macrophage activation we used (4), the second portion was frozen in precooled iso-propaan (5), and the third portion was fixed in Bouin's solution the results of cultures of encapsulated islets alone without macrophages. NR8383 macrophages activated with for paraffin processing (16). GMA sections were prepared at 2 µm and used for 1 µg/ml LPS served as positive controls. This amount of LPS maximally stimulates cytokine production (8).
the following assessments. GMA sections stained with Romanovsky-Giemsa were used to assess the degree of Islets were harvested and processed for measurement of insulin secretion during glucose challenge or processed capsular overgrowth, which was quantified by expressing the number of recovered capsules with overgrowth for glycol methacrylate (GMA) embedding as described below.
as the percentage of the total number of recovered capsules for each individual animal. The same sections were BrdU Labeling of Islets used for assessing the percentage of necrotic tissue in the islets as previously described (13). Briefly, necrosis To label replicating cells in vivo, a bromo-2-deoxyuridine (BrdU) tablet (Boehringer Mannheim) was im-in the retrieved islets was assessed by identifying cells or groups of cells in the islets with the morphological planted subcutaneously via a small incision in the skin of the neck at exactly 6 h before peritoneal lavage.
characteristics of necrosis. To this end, 40-100 recovered islets were microscopically examined to identify For BrdU labeling of encapsulated islet cells in vitro, islets were incubated for 6 h in culture medium contain-cells with a swollen appearance, cells with a loss of plasma integrity, and zones in the islets composed of ing 10 µM BrdU. BrdU labeling was always performed in culture medium containing 15 mM glucose, a concen-cell debris. Subsequently, the necrosis in the islets was quantified by expressing the mean surface area of the tration that stimulates islet cell replication (25) .
islets composed of necrotic tissue as the percentage of Insulin Secretion During Glucose Challenge the total surface area in each individual islet. Also, GMA sections of nonadherent capsules were processed Directly after peritoneal lavage, microencapsulated islets were tested ex vivo in four separate samples of for identification of BrdU-positive cells in the β-cell fraction of the islets. To this end, we applied a double 25 islets for their glucose-induced insulin response. To minimize the variability of the mean insulin responses, staining protocol for the non-β-cell hormones and BrdU as previously described (13). We choose to stain the we meticulously selected islets with diameters between 150 and 200 µm. The encapsulated islets were preincu-non-β-cells in the islets in combination with BrdU instead of β-cells and BrdU because in the grafts we often bated for 45 min in 2 ml Krebs-Ringer-bicarbonate (KRB), gassed with 95% O 2 and 5% CO 2 , containing found degranulated islet cells that would be missed as β-cells when the latter technique was applied. The ade-0.25% BSA and 2.75 mM glucose. The ex vivo insulin secretion was then assessed by three consecutive incuba-quacy of this approach has been shown in a previous study (13). tions of (i) 45 min in 2.75 mM glucose in KRB, (ii) 45 min in 16.5 mM glucose in KRB, and (iii) 45 min in The sections were incubated with a cocktail of the following antibodies: rabbit anti-glucagon (DAKO, Santa 2.75 mM glucose in KRB. At the end of each incubation, the incubation media were removed and frozen for Barbara, CA), rabbit anti-human somatostatin (DAKO), and rabbit anti-human pancreatic polypeptide (DAKO). insulin determination by a radioimmunoassay for insulin (Linco, St. Charles, MO) using rat insulin as a standard.
After several washings, sections were incubated with a goat anti-rabbit, alkaline phosphatase conjugated second Groups of 25 freshly isolated and encapsulated islets served as control. The insulin secretory responses were step reagent. Phosphatase activity was demonstrated by applying Naphtol As-MX phosphate disodium salt and expressed as picogram of insulin L −1 25 islets −1 45 min −1 .
Islets obtained from culture experiments were tested Fast Blue BB salt. Next, the sections were pretreated with HCl for DNA denaturation and incubated with a according to the same procedure with one exception. We applied four separate samples of 10 islets each instead mouse monoclonal antibody against BrdU. After several washing steps the sections were incubated with rabbit ments were fixed in precooled 2% paraformaldehyde, buffered with 0.05 M phosphate, and processed for anti-mouse, peroxidase-conjugated second step reagent. Peroxidase activity was demonstrated by applying 3-GMA embedding. Sections were prepared at 5 µm and processed for immunocytochemical staining of BrdU-amino-9-ethylcarbazole (AEC) containing hydrogen peroxide. Finally, the sections were incubated, in sequence, positive islet cells with staining for non-β-cell hormones. Quantification of islet cell replication was per-in celestin blue and hematoxylin for staining the cell nuclei. All cells in the sections were counted by an in-formed in the same way as specified above for β-cell replication. At least 500 islet cells were counted per ex-vestigator. At least 600 cells were counted per graft. The number of BrdU-positive β-cells was expressed as the periment. Pancreas biopsies were fixed in Bouin's solution for percentage of the total number of counted β-cells.
The second portion of the recovered capsules was paraffin processing, sectioned at 5 µm, and processed for immunocytochemistry as described above for deter-sectioned at 5 µm and processed for immunohistochemical staining as previously described (5 A value of p < 0.05 was considered statistically significant. After several washing steps the sections were incubated with appropriate horseradish peroxidase-conjugated sec-RESULTS ond step reagents. Peroxidase activity was demonstrated by applying 3,3′-diaminobenzidine tetra HCl containing Composition and Degree of Cellular Overgrowth of the Grafts hydrogen peroxide. In control sections we used PBS instead of the first stage monoclonal antibody. This second All five diabetic AO recipients of encapsulated Lewis portion was not only used to study the composition of rat islets became normoglycemic within 5 days after imthe overgrowth but also to assess the number of ED-1plantation and remained normoglycemic for the study and ED-2-positive macrophages in the capsular overperiod of 4 weeks. Encapsulated grafts were retrieved growth. To this end, we counted the macrophages in by peritoneal lavage at 4 weeks after implantation. each graft on at least 100 sectioned overgrown capsules.
The majority of the capsules of 93 ± 6.2% were Then we calculated for each graft the total number of freely floating in the abdominal cavity without adhesion cells on the overgrown capsules, considering the capto the abdominal organs ( Fig. 1) . Occasionally, we sules to be perfect spheres. The cell number was exfound a portion of the capsules adhering to the omentum pressed as a mean number of cells per recovered capor liver capsule. All capsules adhering to the abdominal sules for each individual animal.
The third portion of nonadherent capsules was sectioned at 5 µm and stained for non-β-cell hormones as described above. Subsequently, apoptotic cells were immunostained by applying a modified terminal digoxinucleotidyl transferase (TDT) method (Apoptac, Oncor, Gaithersburg, MD). The apoptotic cells were identified by microscopy. A cell was classified as apoptotic when the nucleus was immunostained and had the characteristic morphology of an apoptotic cell (i.e., a β-cell containing a condensed or fragmented nucleus). Islets in serial slices treated with DNAse I (5 mg/ml, 20 s, 37°C) and lymph nodes in the pancreas served as positive controls. In addition, we quantified apoptosis by assessing the number of apoptotic bodies in GMA-embedded, Romanovsky-Giemsa-stained slices of encapsulated islets.
Processing for GMA embedding and Romanovsky- BrdU-labeled islets obtained from in vitro experi-organs were found to be overgrown by fibrotic tissue The normal percentage of β-cell replication was determined in the pancreas of age-matched nondiabetic con-and occasionally by some macrophages. Of the 93 ± 6.2% capsules retrieved by peritoneal lavage, the mean trols. As shown in Figure 3 , β-cell replication in normoglycemic recipients was eightfold higher in encapsulated percentage of capsules with overgrowth was 9.2 ± 0.3% and varied between 1% and 14%. The composition of islets than in islets in the normal pancreas.
With the exception of a few encapsulated islets the overgrowth on the 9.2 ± 0.3% of free-floating capsules was different from that on capsules adhering to smaller than 100 µm, all encapsulated islets contained necrotic cells. This necrosis varied from single-cell ne-the abdominal organs. The free-floating capsules were surrounded by some fibrotic tissue but the vast majority crosis to almost complete necrosis of the islets, with only a rim of vital islet cells. Necrosis in the islets was of cells were ED-1-and ED-2-positive macrophages. NK cells, granulocytes, CD3 + -bearing T-lymphocytes, or observed to occur almost exclusively in the center and only occasionally in the periphery. In total 37 ± 4% of B-cells were never observed in the histological slices.
The number of ED-1-and ED-2-positive macro-the surface of the islet was composed of necrotic cells. Cells positively stained for apoptosis were rarely ob-phages was quantified in histological slices of free-floating capsules. The total number of macrophages varied served in encapsulated islets. Apoptotic cells were absent in most grafts and present only in low and insuffi-between 10,000 and 24,000 per overgrown capsule. From these assessments follows that with a 9.2% over-cient numbers for reliable quantification in the slices with positively stained cells. The observation that apo-growth rate the quantity of macrophages per capsule amounts to 1542 ± 217.
ptotic cells are rarely present in encapsulated islets confirms our previous observations (13) that necrosis is the Function, Replication, and Cell Death in Explanted major process responsible for islet cell death in the en-Encapsulated Islet Grafts capsulated islets. In view of these results we focused our subsequent in vitro studies on proliferation and necrosis As shown in Figure 2 , the explanted microencapsulated islets always responded to glucose stimulation.
only and abandoned quantification of apoptosis in microencapsulated islets. However, the magnitude of the response was reduced (p < 0.05) when compared with freshly encapsulated is-
The Effect of Rat Macrophages on Function, lets. Also, we found, as in our previous study on explan-Replication, and Cell Death in Encapsulated ted encapsulated islets (13), an incomplete return to Islets In Vitro basal insulin secretion (p < 0.05) during the second incubation in low glucose.
We questioned whether the reduced insulin responses, the hyperproliferation, and the high number of necrotic In islets collected by peritoneal lavage we specifically determined the percentage of replicating β-cells.
cells in the implanted encapsulated islets are caused by tion rate of β-cells. This effect on proliferation of islet cells was even more noticeable in co-incubations of encapsulated islets and LPS-activated macrophages, because β-cells in capsules had completely lost their ability to replicate.
In the absence of macrophages, encapsulated islets were composed of 13 ± 1.3% (n = 5) of necrotic cells. This necrosis varied from single-cell necrosis to almost complete necrosis of the center of the islets. Necrosis was observed to occur mainly centrally and only occasionally peripherally. The severity of necrosis was not associated with the presence of macrophages in the vicinity of the capsules because the mean percentage of necrosis was similar if not identical in encapsulated islets cultured with macrophages or with LPS-activated macrophages. Also, the severity of necrosis was not increased by the presence of the capsule because naked, nonencapsulated islets showed 11 ± 3.2% of necrotic cells (n = 5) in the islets, a percentage similar to the percentage of necrosis in encapsulated islets.
DISCUSSION
It is generally assumed that the loss of islets associated with overgrowth of 2-10% of the encapsulated is- present study we closely mimicked the in vivo situation to evaluate the validity of this assumption. We show that macrophages on the 2-10% of overgrown capsules can influence the functional survival of the graft not only by bioactive molecules secreted by the macrophages on the 9.2 ± 0.3% of overgrown capsules. To answer this ques-overgrowth and subsequent necrosis of the islets but also by release of deleterious bioactive molecules that diffuse tion we designed a coculture system with 1500 macrophages per islet-containing capsule (i.e., the mean num-into the 90-98% of nonovergrown capsules. These macrophage-derived molecules interfere with the efficacy of ber of macrophages per capsule, vide supra), to mimic the in vivo situation. the transplanted islets, as illustrated by our observation that islets co-incubated with macrophages show a dis-As shown in Figure 4 , co-incubation with macrophages had a clear-cut effect on the glucose-induced in-turbed insulin respond to a glucose load. The observation that explanted encapsulated islets sulin response of encapsulated islets. We observed a pronounced reduction of the basal insulin secretion (p < show an incomplete return to basal insulin secretion after glucose challenge confirms our previous study on 0.05) and the glucose-stimulated insulin secretion (p < 0.02) when compared with controls. Also, we observed function of encapsulated islets (13). A similar profile of incomplete return to basal insulin secretion after glucose an incomplete return to basal insulin levels after glucose challenge. This effect of macrophages on insulin secre-challenge was observed in our present in vitro study when encapsulated islets were cocultured with macro-tion was even more pronounced in co-incubations of encapsulated islets with LPS-activated macrophages, be-phages. This suggests that macrophage-derived bioactive factors are responsible for the observed incomplete cause islets in capsules had completely lost their ability to respond to a glucose load when LPS-activated macro-return to basal insulin levels. Our observation that necrosis and not apoptosis of phages were in their direct vicinity.
Co-incubation of encapsulated islets with macro-islet cells is the main cause of cell death and failure of the graft corroborates previous findings (13). The necro-phages did not bring about a hyperproliferation of the encapsulated islets cells (Fig. 3) as observed in explan-sis was mainly located in the central part of the encapsulated islets, which suggests that insufficient nutrition is ted encapsulated islets but rather a sharp decrease in the proliferation rates (Fig. 5 ). Co-incubation of islets with the major cause of graft failure. This necrosis was more severe in encapsulated islets retrieved from the perito-macrophages caused a threefold decrease in the replica- neal cavity than in those harvested in vitro. Plausibly, this is caused by the less favorite in vivo situation in which factors such as oxygen tension are lower than in vitro (11). A new and surprising observation is that the necrosis was not influenced by the presence of a capsule around the islets because the quantity of necrotic cells was similar in free and encapsulated cultured islets. Obviously, the capsule as such does not interfere with diffusion of essential nutrients into the islets. The necrosis is therefore caused by too slow diffusion of nutrients through the outer cells layers of the islets.
Our present data on hyperproliferation of islet cells confirms previous observations that encapsulated islet cells show an extreme increase in proliferation rate after transplantation (13). The hyperproliferation of islet cells in vivo warrants some further consideration, because the hyperproliferation should not be interpreted as insufficient to compensate for the increased cell death but rather as a detrimental factor in itself. At least two mechanisms may be involved, basically by interfering with the islet composition. Because nonendocrine islet cells like fibroblasts have high replication rates, the nonendocrine cell mass will grow faster than the β-cell mass. This occurs predominantly in the capsule periphery, because there the concentration of nutrients is highest. The nutrition in the core of the capsule becomes increasingly insufficient, with ischemia of β-cells and disturbs the normal ratio of insulin-producing and non-
